These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676 [TBL] [Abstract][Full Text] [Related]
67. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment. Massicotte G; Kessler M; Lynch G; Baudry M Mol Pharmacol; 1990 Feb; 37(2):278-85. PubMed ID: 2154675 [TBL] [Abstract][Full Text] [Related]
69. Receptor site specificity for the acute effects of beta-N-methylamino-alanine in mice. Smith SE; Meldrum BS Eur J Pharmacol; 1990 Oct; 187(1):131-4. PubMed ID: 1980247 [TBL] [Abstract][Full Text] [Related]
70. Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Birch PJ; Grossman CJ; Hayes AG Eur J Pharmacol; 1988 Jul; 151(2):313-5. PubMed ID: 2901972 [TBL] [Abstract][Full Text] [Related]
71. Comparison of ethanol sensitivity of rat brain kainate, DL-alpha-amino-3-hydroxy-5-methyl-4-isoxalone proprionic acid and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Dildy-Mayfield JE; Harris RA J Pharmacol Exp Ther; 1992 Aug; 262(2):487-94. PubMed ID: 1380078 [TBL] [Abstract][Full Text] [Related]
72. Comparison of the anticonvulsive activities of organic mono- and dications with their abilities to inhibit NMDA and AMPA glutamate receptors. Lukomskaya NY; Rukoyatkina NI; Gorbunova LV; Gmiro VE; Bol'shakov KV; Magazanik LG Neurosci Behav Physiol; 2004 Feb; 34(2):181-7. PubMed ID: 15115325 [TBL] [Abstract][Full Text] [Related]
73. General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Carlà V; Moroni F Neurosci Lett; 1992 Oct; 146(1):21-4. PubMed ID: 1282227 [TBL] [Abstract][Full Text] [Related]
75. The anticonvulsant action of CI-977, a selective kappa-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex. Singh L; Vass CA; Hunter JC; Woodruff GN; Hughes J Eur J Pharmacol; 1990 Dec; 191(3):477-80. PubMed ID: 1964913 [TBL] [Abstract][Full Text] [Related]
76. Long-lasting ibogaine protection against NMDA-induced convulsions in mice. Leal MB; de Souza DO; Elisabetsky E Neurochem Res; 2000 Aug; 25(8):1083-7. PubMed ID: 11055745 [TBL] [Abstract][Full Text] [Related]
77. Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice. Budziszewska B; Siwanowicz J; Leśkiewicz M; Jaworska-Feil L; Lasoń W Eur Neuropsychopharmacol; 1998 Feb; 8(1):7-12. PubMed ID: 9452934 [TBL] [Abstract][Full Text] [Related]
78. Influence of NMDA receptor ligands on thyrotropin-releasing hormone-induced scratching in rabbits. Popoli P; Caporali MG; Scotti de Carolis A Eur J Pharmacol; 1995 Jan; 272(1):119-21. PubMed ID: 7713144 [TBL] [Abstract][Full Text] [Related]
79. A dipeptide derived from kainic and L-glutamic acids: a selective antagonist of amino acid induced neuroexcitation with anticonvulsant properties. Goldberg O; Teichberg VI J Med Chem; 1985 Dec; 28(12):1957-8. PubMed ID: 2866249 [TBL] [Abstract][Full Text] [Related]
80. The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist. Klockgether T; Jacobsen P; Löschmann PA; Turski L J Neural Transm Park Dis Dement Sect; 1993; 5(2):101-6. PubMed ID: 8333906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]